Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions

Nature Structural and Molecular Biology

Volumn 16, Issue 12, 2009, Pages 1244-1251

  Cesare, Anthony J ^a,b   Kaul, Zeenia ^a,b   Cohen, Scott B ^a,b   Napier, Christine E ^a,b   Pickett, Hilda A ^a,b   Neumann, Axel A ^a,b   Reddel, Roger R ^a,b  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEIC ACID BINDING PROTEIN; PROTEIN P53; REC PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CAPPING PHENOMENON; CELL CYCLE; CELL IMMORTALIZATION; CELL LINE; CHROMOSOME; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; GENE FUSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SISTER CHROMATID; TELOMERE; WILD TYPE;

CELL LINE; CHROMOSOMES, HUMAN; DNA DAMAGE; HUMANS; MODELS, BIOLOGICAL; RECOMBINASES; TELOMERASE; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 2;

EID: 71449119003     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.1725     Document Type: Article

References (42)

1. Palm, W. & de Lange, T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42, 301-334 (2008).
2. Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549-1556 (2003).
3. Denchi, E.L. & de Lange, T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448, 1068-1071 (2007).
4. Guo, X. et al. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J. 26, 4709-4719 (2007).
5. Smogorzewska, A. & de Lange, T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21, 4338-4348 (2002).
6. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. & de Lange, T. p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325 (1999).
7. d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198 (2003).
8. Smogorzewska, A., Karlseder, J., Holtgreve-Grez, H., Jauch, A. & de Lange, T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 12, 1635-1644 (2002).
9. Colgin, L.M. & Reddel, R.R. Telomere maintenance mechanisms and cellular immortalization. Curr. Opin. Genet. Dev. 9, 97-103 (1999).
10. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. & Reddel, R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248 (1995).
11. Bryan, T.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A. & Reddel, R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3, 1271-1274 (1997).
12. Perrem, K. et al. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18, 3383-3390 (1999).
13. Dunham, M.A., Neumann, A.A., Fasching, C.L. & Reddel, R.R. Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450 (2000).
14. Jiang, W.Q. et al. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of MRE11/RAD50/NBS1 complex. Mol. Cell. Biol. 25, 2708-2721 (2005).
15. Cesare, A.J. & Reddel, R.R. Telomere uncapping and alternative lengthening of telomeres. Mech. Ageing Dev. 129, 99-108 (2008).
16. Wang, R.C., Smogorzewska, A. & de Lange, T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119, 355-368 (2004).
17. Celli, G.B., Denchi, E.L. & de Lange, T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 8, 885-890 (2006).
18. Wu, L. et al. Pot1 defciency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126, 49-62 (2006).
19. Palm, W., Hockemeyer, D., Kibe, T. & de Lange, T. Functional dissection of human and mouse POT1 proteins. Mol. Cell. Biol. 29, 471-482 (2009).
20. Cesare, A.J. & Griffth, J.D. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol. Cell. Biol. 24, 9948-9957 (2004).
21. Nabetani, A., Yokoyama, O. & Ishikawa, F. Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J. Biol. Chem. 279, 25849-25857 (2004).
22. Verdun, R.E., Crabbe, L., Haggblom, C. & Karlseder, J. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol. Cell 20, 551-561 (2005).
23. Nakamura, A.J. et al. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin 1, 6 (2008).
24. Anderson, M.J., Casey, G., Fasching, C.L. & Stanbridge, E.J. Evidence that wild-type TP53, and not genes on either chromosome I or II, controls the tumorigenic phenotype of the human fbrosarcoma HT1080. Genes Chromosom. Cancer 9, 266-281 (1994).
25. Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 (1998).
26. Cohen, S.B. & Reddel, R.R. A sensitive direct human telomerase activity assay. Nat. Methods 5, 355-360 (2008).
27. Henson, J.D., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610 (2002).
28. Murnane, J.P., Sabatier, L., Marder, B.A. & Morgan, W.F. Telomere dynamics in an immortal human cell line. EMBO J. 13, 4953-4962 (1994).
29. Bailey, S.M., Cornforth, M.N., Kurimasa, A., Chen, D.J. & Goodwin, E.H. Strand-specifc postreplicative processing of mammalian telomeres. Science 293, 2462-2465 (2001).
30. Yeager, T.R. et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179 (1999).
31. Perrem, K., Colgin, L.M., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21, 3862-3875 (2001).
32. Pickett, H.A., Cesare, A.J., Johnstone, R.L., Neumann, A.A. & Reddel, R.R. Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J. 28, 799-809 (2009).
33. Sprung, C.N., Bryan, T.M., Reddel, R.R. & Murnane, J.P. Normal telomere maintenance in immortal ataxia telangiectasia cell lines. Mutat. Res. 379, 177-184 (1997).
34. Bernardi, R. & Pandolf, P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006-1016 (2007).
35. Griffth, J.D. et al. Mammalian telomeres end in a large duplex loop. Cell 97, 503-514 (1999).
36. Stansel, R.M., de Lange, T. & Griffth, J.D. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J. 20, 5532-5540 (2001).
37. Verdun, R.E. & Karlseder, J. Replication and protection of telomeres. Nature 447, 924-931 (2007).
38. Bae, N.S. & Baumann, P.A. RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell 26, 323-334 (2007).
39. Verdun, R.E. & Karlseder, J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127, 709-720 (2006).
40. Crabbe, L., Verdun, R.E., Haggblom, C.I. & Karlseder, J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306, 1951-1953 (2004).
41. Ding, H. et al. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 117, 873-886 (2004).
42. Konishi, A. & de Lange, T. Cell cycle control of telomere protection and NHEJ revealed by a ts mutation in the DNA-binding domain of TRF2. Genes Dev. 22, 1221-1230 (2008).